An observational study in Acute Kidney Injury and Kidney Diseases, sponsored by Guy's and St Thomas' NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-23.
Sponsored by Guy's and St Thomas' NHS Foundation Trust · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Acute Kidney Injury by Guy's and St Thomas' NHS Foundation Trust — 3 open to participants now, 5 under way, none of them phase 3. Acute Kidney Injury · Guy's and St Thomas' NHS Foundation Trust.
Among the 12 studies in Acute Kidney Injury by Guy's and St Thomas' NHS Foundation Trust, this one is the only one that started in 2023, is one of 9 observational ones, and was the 9th registered.
1,693 studies on the registry are indexed under Acute Kidney Injury; 392 are open to participants now.
Browse Acute Kidney Injury studies →3 of the 12 studies in Acute Kidney Injury by Guy's and St Thomas' NHS Foundation Trust are open now, in 1 country. Recruiting first, the newest first:
Guy's and St Thomas' NHS Foundation Trust · Sites in United Kingdom
Ages 18+
Guy's and St Thomas' NHS Foundation Trust · Sites in United Kingdom
Ages 18+
By country, each count listing its studies:
Of the 229 Acute Kidney Injury studies recruiting now, 161 (70%) set no upper age limit and 35 (15%) stop at 75 or younger; 22 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 1 started in 2023.
This study's planned enrollment of 100 is below the median of 160 across 814 observational studies indexed under Acute Kidney Injury.
Median enrollment 20 across the 3 interventional studies, 100 across the 9 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Guy's and St Thomas' NHS Foundation Trust is the lead sponsor of 295 studies on the registry; 80 are open to participants now.
1 of the studies in Acute Kidney Injury by Guy's and St Thomas' NHS Foundation Trust that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07447791Guy's and St Thomas' NHS Foundation TrustWISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients | 2027-01-31 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Acute Kidney Injury by Guy's and St Thomas' NHS Foundation Trust, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators will investigate whether new kidney biomarkers can identify patients who are at risk of chronic kidney disease after an episode of moderate / severe acute kidney injury in ICU.
Acute kidney injury (AKI) is a common complication during critical illness and associated with serious short and long-term complications. Participants with AKI have an increased risk of developing dysfunction of other organs, including multi-organ failure, a longer stay in hospital and a higher risk of dying. Survivors remain at risk of complications, even if kidney function initially recovers. In particular, they are at high risk of developing chronic kidney disease, dialysis-dependent end-stage kidney disease and cardiovascular comorbidities. At present, the tools to identify patients at highest risk of chronic kidney disease (CKD) are very limited.
The investigators will recruit participants who had AKI whilst in ICU and are scheduled to be discharged from hospital. Within 3 days of discharge from hospital, blood and urine kidney biomarkers will be measured to explore whether there is a correlation with renal function 3 months later and to identify those at highest risk of CKD. In addition, quality of life at 3 months will be assessed.
critically ill adult patients in the ICU
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
critically ill adult patients who had AKI stage II or III whilst in ICU and are scheduled to be discharged from hospital
Exclusion Criteria:
Patients who suffered from AKI whilst in ICU and are awaiting discharge from hospital
serum creatinine
estimated glomerular filtration rate (eGFR) \<60ml/min
Time frame: 3 months after discharge from hospital
mortality
mortality
Time frame: 90 days
cardiovascular morbidity
new or worsened cardiovascular morbidity
Time frame: 3 months post hospitalisation
questionnaire
health-related quality of life based on questionnaire EQ-5D-5L
Time frame: 3 months post hospitalisation
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2023 (actual). Primary completion is estimated for Jan 2025, 22 months after the start.
Of 350 non-industry observational studies under Acute Kidney Injury, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 22 months is close to that.
Counting every sponsor, half of 365 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Guy's and St Thomas' NHS Foundation Trust →